Downregulation of NEAT1 reverses the radioactive iodine resistance of papillary thyroid carcinoma cell via miR-101-3p/FN1/PI3K-AKT signaling pathway

Considering the resistance of papillary thyroid cancer (PTC) (131)I therapy, this study was designed to find a solution at molecular respect. By probing into lncRNA-NEAT1/miR-101-3p/FN1 axis and PI3K/AKT signaling pathway, this study provided a potential target for PTC therapy. (131)I-resistant cell...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cell Cycle
Autori principali: Liu, Chao, Feng, Zhiping, Chen, Ting, Lv, Juan, Liu, Pengjie, Jia, Li, Zhu, Jialun, Chen, Fukun, Yang, Chuanzhou, Deng, Zhiyong
Natura: Artigo
Lingua:Inglês
Pubblicazione: Taylor & Francis 2018
Soggetti:
Research Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6343742/
https://ncbi.nlm.nih.gov/pubmed/30596336
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384101.2018.1560203
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi